The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Directors and Issue of Equity

21 Jan 2010 17:56

RNS Number : 9562F
Cathay International Holdings Ld
21 January 2010
 



21 January 2010

Cathay International Holdings Limited 

('Cathay' or the 'Company'

Appointment of Directors and Issue of Equity

Appointment of new Chief Executive Officer, Finance Director and Issue of Equity

Cathay is pleased to announce the appointment of Mr Lee Jin-Yi ("Mr Lee") and Mr Siu Ka Chi Eric ("Mr Siu") to the Board of Directors (the "Board") of the Company with immediate effect. Mr Lee, who has been appointed Chief Executive Officer, and Mr Siu, who has been appointed Finance Director, were appointed by resolutions passed at the Company's Board Meeting yesterday.

The Company is also pleased to announce that Mr Wu Zhen Tao ("Mr Wu"), former Chief Executive Officer of the Cathay, will remain as an executive director of the Company and has been appointed Chairman of a newly-formed Executive Committee. The Executive Committee comprises of all the Company's executive directors and such other senior executives as the Board shall appoint. The Executive Committee shall assist the Board in monitoring and supervising the operations of Cathay.

Prior to joining Cathay, Mr. Lee was Managing Director and Chief Executive Officer of Fubon Bank (Hong Kong) Ltd. for five and half years  and a director of Fubon Financial Holding Co., Ltd. and Xiamen City Commercial Bank. Mr Lee has extensive experience in the banking industry. He was the Head of Corporate Finance, Asia and a member of the Management Committee of BNP Paribas Peregrine. Prior to thathe worked at JP Morgan for 17 years, most recently as Managing Director and China Senior Country Officer of J.P. Morgan Chase & Co. Mr Lee was also a committee member of the Hong Kong Association of Banks from 1998 to 2000. Mr Lee graduated from National Taiwan University and obtained an MBA from Harvard University.

Today, the Company has agreed to issue, under the authority granted to the Board at the Special General Meeting of the Company held on 4 December 2009, 1,842,353 new common shares of US$0.05 each in the Company (the "Initial New Common Shares") for which Mr. Lee will subscribe fully at a price of 33 pence per share (the "Subscription Price") for a total cash consideration of US$1,000,000. The Subscription Price represents a discount of approximately 10.8to the closing middle market price of 37 pence on 20 January 2010, and a premium of approximately a 2.7% to the average closing price of 32.13 pence during the last 30 trading days immediately prior to the date of this announcement. 550,000 Initial New Common Shares will be issued to Mr Lee today. The remaining 1,292,353 Initial New Common Shares will be issued to Mr Lee at the Subscription Price only when the Company is able to do so in circumstances which would not cause the percentage of the Company's common shares held in public hands to fall below twenty five per cent.

Under the terms of Mr Lee's service contract, the Company has agreed to issue 1,842,353 new common shares of US$0.05 each in the Company (the "Grant Shares") to Mr Lee annually, in five approximately equal tranches over a five year period. The Grant Shares will only be issued to Mr Lee at the discretion of the Company if approved by the remuneration committee of the Company, and only where to do so would not cause the percentage of the Company's common shares held in public hands to fall below twenty five per cent. Mr Lee's service contract can be terminated by the Company on three months' notice. If his service contract is terminated, Mr Lee's right to receive any of the Grant Shares not yet received by him would also be terminated.

Mr Siu joined Cathay in 1998, bringing with him over 14 years of banking and finance experience in the areas of corporate finance, mergers and acquisitions, and structured finance advisory services. Prior to joining Cathay, he worked with Banco Santander Group, Barclays Bank Group and Ernst & Young. He is a member of The Institute of Chartered Accountants in England and Wales and a fellow member of the Association of Chartered Certified Accountants. Mr Patrick Sung will remain on the Board as an executive director and will operate closely with Mr Siu as Financial Controller to Company.

Mr Sum Soon Lim, Chairman of the Company, commented:

"The appointment of Messrs Lee and Siu demonstratethe Board's commitment to strengthening the professional management of Cathay as it has reached a critical inflection point in its development. It will also allow more time for Mr Wu to concentrate on the Company's strategic development and growth plans for the future."

Listing Rules Disclosures

Mr Lee holds, or has in the last five years held, the following directorships:

DETAILS OF PRESENT DIRECTORSHIPS

From 

To 

Company

Country of Incorporation

Role

11/08

Present (expires 04/10)

Xiamen City Commercial Bank

People's Republic of China

Director

DETAILS OF PAST DIRECTORSHIPS IN THE LAST 5 YEARS

From 

To 

Company

Country of Incorporation

Role

7/04

11/09

Fubon Bank (Hong Kong) Ltd 

Hong Kong

Managing Director and Chief Executive Officer

10/07

10/09

Fubon Financial Holding Co., Ltd.

Taiwan

Director

Mr Siu does not hold, and has not held, any directorship at any time in the last five years (other than currently as a director of certain subsidiaries of Cathay) and is not, and has not been, a partner in any partnership at any time in the last five years.

There are no further details to be disclosed under paragraph 9.6.13 of the Listing Rules.

Appointment of New Company Secretary

Cathay is also pleased to announce that Ms Rebecca Yip Pui Ling ("Ms Yip") has been appointed as Company Secretary with effect from 8 January 2010. Ms Yip joined Cathay in 1994. She is a fellow member of The Hong Kong Institute of Certified Public Accountants and The Association of Chartered Certified Accountants, and a member of The Institute of Chartered Accountants in England and Wales. She is also an associate of The Institute of Chartered Secretaries and Administrators and The Hong Kong Institute of Company Secretaries. 

The Company confirms that Ms Linda Carter ("Ms Carter") has resigned as Company Secretary with effect from 8 January 2010. The Board would like to take this opportunity to express its gratitude to Ms Carter for her contribution to the Company.

Issue of Equity

The Company announces that it has today agreed to issue under the authority granted to the Board at the Special General Meeting of the Company held on 4 December 2009 a further 3,200,000 new common shares of US$0.05 each in the Company (the "Further New Common Shares") to a wholly owned subsidiary of the Company (the "Subsidiary"also at a subscription price of 33 pence per share for a total cash consideration of US$1,736,909. The subscription price represents a discount of approximately 10.8to the closing middle market price of 37 pence on 20 January 2010, and approximately a 2.7% premium over the average closing price of 32.13 pence during the last 30 trading days immediately prior to the date of this announcement.  The Further New Common Shares will be held by the Subsidiary until such time as the Company determines that they may either be sold in the market or returned to be held by the Company or cancelled as the Directors deem appropriate. It is the current intention that the Further New Common Shares may be sold in the market to reduce the cost of any increase in the value of any future share based payments.

The Initial New Common Shares, the Grant Shares and the Further New Common Shares will rank pari passu with the existing common shares in all respects. The proceeds from the issue of the Initial New Common Shares will be used for general working capital purposes. 

Application for  those Initial New Common Shares to be issued to Mr Lee today to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities will be made at the earliest practical opportunity.

Enquiries:

Stephen Hunt

Cathay

Tel: +852 2828 9289

Jon Coles

Brunswick

Tel: +44 207 4045959

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUASBRRBAAUAR
Date   Source Headline
2nd Apr 20157:00 amRNSGrant of Share Options
30th Mar 20157:35 amRNSRepeat of Annual Results Announcement RNS 7096I
27th Mar 201512:14 pmRNSAnnual Results for the Year Ended 31 December 2014
25th Mar 20157:00 amRNSHolding(s) in Company
12th Mar 20157:00 amRNSNotice of Annual Results 2014
5th Jan 20159:16 amRNSLansen's New Distribution Agreement
18th Dec 20148:36 amRNSLansen and Haotian Renew Supply Agreement
29th Aug 20149:26 amRNSInterim results for six months ended 30 June 2014
19th Aug 20147:00 amRNSNotice of Interim Results 2014
23rd May 201410:38 amRNSResult of AGM
19th May 20147:00 amRNSInterim Management Statement
7th Apr 20148:58 amRNSGrant of Share Options
31st Mar 20147:00 amRNSAcquisition of Sicorten Plus in the PRC
28th Mar 20148:47 amRNSAnnual Results for the Year Ended 31 December 2013
14th Mar 20147:00 amRNSNotice of Annual Results
19th Nov 20137:00 amRNSInterim Management Statement
15th Oct 201310:24 amRNSTransfer of Misoprostol Development Project
3rd Sep 20131:31 pmRNSLansen and Haotian Sign Supply Agreement
30th Aug 20139:42 amRNSInterim Results for the six months ended June 2013
19th Aug 20139:24 amRNSNotice of Interim Results
21st May 20137:00 amRNSResults of Annual General Meeting
16th May 20137:00 amRNSInterim Management Statement
11th Apr 20137:00 amRNSAnnual Report and Accounts
4th Apr 20139:03 amRNSGrant of Share Options
27th Mar 20138:30 amRNSAnnual Results for the Year Ended 31 December 2012
14th Mar 20139:33 amRNSNotice of Annual Results 2012
6th Mar 20138:30 amRNSCathay's subsidiary Lansen board change
26th Feb 201310:37 amRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20128:55 amRNS1.5% holding in Zhejiang Starry Pharmaceutical Co.
19th Nov 20127:00 amRNSInterim Management Statement
29th Aug 201212:15 pmRNSTotal Voting Rights and Share Capital
29th Aug 20129:23 amRNSInterim results
15th Aug 20127:00 amRNSNotice of Interim Results
25th May 201211:26 amRNSResult of AGM
21st May 20127:00 amRNSAnnual Information Update
17th May 20127:00 amRNSInterim Management Statement
10th May 20127:00 amRNSLicense for collagen injectable filler
20th Apr 20129:15 amRNSAnnual Report and Accounts
3rd Apr 201210:50 amRNSGrant of Share Options
29th Mar 20129:32 amRNSAnnual Results for the Year Ended 31 December 2011
19th Mar 201210:00 amRNSNotification of Annual Results
27th Feb 20129:43 amRNSLansen Received Technology Endorsement
9th Jan 20129:00 amRNSLansen signs exclusive agreement
18th Nov 20117:00 amRNSInterim Management Statement
26th Oct 20119:47 amRNSLansen signs exclusive agreement with Ethypharm
25th Aug 20115:00 pmRNSInterim Results
15th Aug 201111:12 amRNSNotice of Interim Results
20th May 20117:00 amRNSAnnual Information Update
19th May 20117:00 amRNSInterim Management Statement
6th Apr 20117:00 amRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.